Assessment of suicidal behavior in dermatology (Review).
acne
dermatology
melanoma
psoriasis
suicidal behavior
Journal
Experimental and therapeutic medicine
ISSN: 1792-0981
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
20
09
2019
accepted:
21
10
2019
entrez:
9
6
2020
pubmed:
9
6
2020
medline:
9
6
2020
Statut:
ppublish
Résumé
Many diseases that affect physical health can also affect mental health. Many of these diseases are studied in terms of quality of life, depression and suicidal behavior. Dermatological disorders, although having a strong impact on the individual's life, are less studied with regard to suicidal behavior. There is a need to approach several dermatological diseases from the perspective of suicidal behavior in order to intervene early with specific treatment or to prevent suicide. Psoriasis, acne, melanoma, atopic dermatitis and urticaria are scarcely studied from the point of view of suicidal behavior. In addition to these diseases, there are others that require attention in terms of suicidal behavior, such as vitiligo or oculocutaneous albinism, most probably due to a small number of people suffering from these diseases, research is almost non-existent in these cases. We want to draw attention to the importance of early detection of suicidal behavior in dermatological practice and to highlight the need for several studies on this subject.
Identifiants
pubmed: 32508997
doi: 10.3892/etm.2019.8145
pii: ETM-0-0-8145
pmc: PMC7271711
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
73-77Informations de copyright
Copyright © 2020, Spandidos Publications.
Références
J Invest Dermatol. 2014 Jul;134(7):1847-1854
pubmed: 24496238
J Am Acad Dermatol. 2006 Mar;54(3):420-6
pubmed: 16488292
Psychiatry Res. 2004 Apr 30;126(2):167-75
pubmed: 15123396
Am J Psychiatry. 2014 Oct;171(10):1045-51
pubmed: 25272344
Expert Opin Drug Saf. 2016 Dec;15(12):1653-1659
pubmed: 27554637
BMJ. 2019 Feb 6;364:l94
pubmed: 31339847
J Invest Dermatol. 2015 Apr;135(4):984-991
pubmed: 25521458
Clin Exp Dermatol. 2014 Jul;39(5):624-7
pubmed: 24934916
J Am Acad Dermatol. 2017 Sep;77(3):425-440.e2
pubmed: 28807109
Exp Ther Med. 2019 Feb;17(2):997-1003
pubmed: 30679965
Contact Dermatitis. 2006 Feb;54(2):106-11
pubmed: 16487283
J Am Acad Dermatol. 2008 Nov;59(5):746-51
pubmed: 19119094
Suicide Life Threat Behav. 2006 Feb;36(1):120-4
pubmed: 16676633
Biomed Res Int. 2014;2014:504279
pubmed: 24678508
Clin Dermatol. 2013 Jan-Feb;31(1):101-9
pubmed: 23245981
Ann Oncol. 2013 Dec;24(12):3112-7
pubmed: 24169626
Hautarzt. 2009 Aug;60(8):641-6
pubmed: 19399379
BMJ. 1989 Apr 8;298(6678):964
pubmed: 2497882
J Eur Acad Dermatol Venereol. 2006 Apr;20(4):464-5
pubmed: 16643152
J Eur Acad Dermatol Venereol. 2013 Apr;27(4):473-8
pubmed: 22339940
J Am Acad Dermatol. 2016 Jul;75(1):237-9
pubmed: 27317530
Lancet. 2007 Sep 8;370(9590):859-77
pubmed: 17804063
J Paediatr Child Health. 2006 Dec;42(12):793-6
pubmed: 17096715
BMJ Open. 2016 Jan 13;6(1):e009074
pubmed: 26769782
Exp Ther Med. 2019 Feb;17(2):1078-1084
pubmed: 30679977
Exp Ther Med. 2019 Aug;18(2):916-925
pubmed: 31384324
Acta Derm Venereol. 2004;84(3):205-12
pubmed: 15202837
Australas J Dermatol. 2010 Nov;51(4):248-53
pubmed: 21198520
Acta Derm Venereol. 2017 Nov 15;97(10):1189-1195
pubmed: 28676884
Psychosom Med. 1994 Jan-Feb;56(1):36-40
pubmed: 8197313
Hautarzt. 2008 Apr;59(4):289-96
pubmed: 18338146
Int J Dermatol. 1993 Mar;32(3):188-90
pubmed: 8444530
BMJ Case Rep. 2013 Dec 17;2013:
pubmed: 24347450
Br J Dermatol. 1998 Nov;139(5):846-50
pubmed: 9892952
Acta Derm Venereol. 2012 Sep;92(5):543-6
pubmed: 22068440
Patient Prefer Adherence. 2018 Apr 24;12:625-635
pubmed: 29731610
J Crohns Colitis. 2010 Nov;4(5):591-3
pubmed: 21122565
Br J Dermatol. 1997 Aug;137(2):246-50
pubmed: 9292074